Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders
Our study suggests that VMAT2 inhibitors are effective for treating pediatric hyperkinetic movement disorders. Furthermore, this study provides insights into barriers to access to these drugs by pediatric patients.
Authors
- Mariam Hull (ORCID: https://orcid.org/0000-0002-7340-1660)
- Joseph Jankovic
- Sujal Manohar (ORCID: https://orcid.org/0000-0001-7128-7043)
- Ruud Berger (ORCID: https://orcid.org/0009-0009-1790-3672)
- Jennifer Jacobe
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
Publication Details
- Journal
- Tremor and Other Hyperkinetic Movements
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5334/tohm.1023
- Citations
- 1
- Primary Topic
- Glycogen Storage Diseases and Myoclonus
- Type
- article
- Field-Weighted Citation Impact
- 1.67